Discover investment opportunities in Growth Hospitals Stocks In 2025 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Growth Hospitals Stocks In 2025 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Growth Hospitals Stocks In 2025 using our Smart AI Filter.
9 stocks found for "Growth Hospitals Stocks In 2025"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.04 | ±27.0% | 15.3 | 0.76% | |||
1.57 | ±53.2% | 17.6 | 0.00% | |||
0.69 | ±55.6% | 6.4 | 0.00% | |||
0.99 | ±40.0% | 15.0 | 0.06% | |||
0.97 | ±38.7% | 24.4 | 0.00% | |||
3.75 | ±100.0% | 6.7 | 1.67% | |||
0.76 | ±30.1% | 10.2 | 0.44% | |||
1.62 | ±65.1% | 9.7 | 0.00% | |||
0.35 | ±21.1% | 24.9 | 0.57% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
The consensus price target hints at a 39.9% upside potential for The Pennant Group (PNTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read moreQ: How do economic downturns typically affect hospital stocks like UHS or HCA?
A: Hospital stocks, such as UHS and HCA, often exhibit resilience during economic downturns due to the non-discretionary nature of healthcare services. However, profitability may be pressured by higher bad debt expenses and reduced elective procedures. Investors may consider historical performance data for further insights.
Q: What ESG factors impact hospital stocks such as ACHC or Encompass Health?
A: ESG factors affecting ACHC and Encompass Health include access to quality care, diversity in governance, and sustainability practices. Enhanced focus on patient care and regulatory compliance may positively influence investor perception and long-term prospects.
Q: Are hospitals like CYH and THC considered good for dividend income?
A: Hospitals like CYH and THC may not be traditionally seen as dividend stocks due to capital-intensive business models and potential volatility. Investors should review each company's financial health, payout ratios, and sector norms for clarity.
Q: Which competitive advantages do companies such as SGRY and SEM offer over traditional hospital providers?
A: Companies like SGRY and SEM may offer competitive advantages through specialized surgical centers and outpatient services, providing cost efficiencies and targeted care, potentially attracting acquisitive investors. Understanding each entity’s market positioning is crucial for analysis.
Q: What are potential growth drivers for hospital stocks like EHC and PNTG going into the future?
A: Future growth drivers for EHC and PNTG may include expansion in outpatient services, strategic acquisitions, and increased aging population demanding more healthcare services. Investors often track company strategies and industry trends to evaluate potential upside.
Q: How do hospital stocks like HCA and UHS generally behave in inflationary periods?
A: In inflationary periods, hospital stocks such as HCA and UHS may face challenges with rising labor and supply costs. However, their ability to pass costs onto patients through negotiated insurance rates could mitigate impacts. Historical data offers insights into performance during inflation.